Skip to content
DraconiticResearch
Search Sources API
220,595 studies31 sourcesUpdated 56 min ago

Oncology

5,778 studies502 in 7 days2,682 in 30 days

Filters
Type
Date
Clear

Latest

5,778 studies

  1. Repositioning of cis-flupentixol for the suppression of ovarian cancer cell migration and invasion through ERK5 inhibition
    Li Hyun Kim, Yul Min Lee, Dain Kim +2
    Molecular MedicinePeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  2. Integrated analysis identifies an aging-related prognostic signature for lung adenocarcinoma
    Rui Zhang, Xinyi Chen, Na Li +1
    BMC CancerPeer-reviewedCC BY 4.0Full textOncologyPMC
  3. Assessment of Cancer‐Related Cognitive Impairments Across Anti‐Cancer Therapies in a Predominantly Breast Cancer Cohort
    Qiqi Lei, Martina E. Schmidt, Philipp Zimmer +3
    International Journal of CancerPeer-reviewedCC BY 4.0Full textOncologyPMC
  4. Development and validation of a machine learning–based model for predicting textbook outcome after minimally invasive pancreaticoduodenectomy
    Yu Zhang, Xiaoqin Lu, Xiuping Weng +2
    BMC SurgeryPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  5. Surgery Utilization Mediates Survival in Patients With Dementia and Stage I–III Colorectal Cancer
    Evan M. Abbey, Vashisht V. Madabhushi, Meghan E. Lark +3
    Journal of the American Geriatrics SocietyPeer-reviewedCC BY 4.0Full textOncologyPMC
  6. Dual Checkpoint Inhibition With or Without Chemotherapy in Metastatic NSCLC: A Reconstructed Individual Patient Data Meta-Analysis.
    Skyler Taylor, Isadora Mamede, Gabriela Gazzoni +6
    JTO clinical and research reportsPeer-reviewedCC BYFull textOncologyEurope PMC
  7. Two Faces of UV Mutagenesis: Independent and Collateral Mutagenesis in Skin Cancers
    Konstantin Gunbin, Zamart Ramazanova, Bakhyt Matkarimov +3
    LifePeer-reviewedCC BY 4.0Full textOncologyHAL
  8. Prospective multicentre study evaluating ctDNA as a biomarker of residual disease after chemoradiotherapy for locally advanced head and neck squamous cell carcinoma: NeckTAR-IN protocol
    Angeline Ginzac, Léo Ventelou, Marie-Céleste Ferreira +9
    BMJ OpenPeer-reviewedCC BY-NC 4.0Full textOncologyHAL
  9. IL-6-driven metabolic reprogramming of the multiple myeloma microenvironment
    María Matamala Montoya, Silke Eleveld, Esther A. Zaal +1
    Cancer & MetabolismPeer-reviewedCC BY 4.0Full textOncologyPMC
  10. Simulation-based Bayesian deep learning enables uncertainty-aware tumor fraction estimation in cell-free DNA
    Hadas Volkov, Maria Raitses-Gurevich, Meitar Grad +5
    BioData MiningPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  11. Prognostic impact of the Gustave Roussy Immune score in metastatic renal cell carcinoma treated with first-line immunotherapy-based combinations: results from the Turkish Oncology Group Kidney Cancer Consortium (TKCC)
    Aysun Fatma Akkuş, Hatice Bölek, Esma Kaplan Tüzün +18
    BMC CancerPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  12. Synergistic induction of pyroptosis-like cell death in colorectal cancer cells by norcantharidin and low-dose oxaliplatin promotes M1 macrophage polarization
    Jia Lang, XueLian Zhu, Qian Chen +3
    BMC CancerPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  13. Atypical lipomatous tumor of buccal mucosa, misdiagnosis as myxoid lipoma: a case report
    Ata Garajei, Matin Abdoos, Monir Moradzadeh Khiavi +2
    Journal of Medical Case ReportsPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  14. Exercise-induced metabolic reprogramming in lung cancer and its translational implications for therapeutic advancement
    Yonghua Zheng, Yisheng Chen, Hanyang Zhao +6
    Journal of Translational MedicinePeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  15. Pretreatment serum IRAK4 and NLRP3 concentrations, their combined score, and overall survival in non-small cell lung cancer: a retrospective single-center cohort study
    Han Qiao, Xiaolei Han, Lei Zhao +1
    BMC CancerPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  16. Clinical insights into the genomic landscape of ESR1-mutated breast cancer and implications for treatment decision-making: a large-scale analysis of 6,162 patients
    Linhao Xie, Mengxiao Wang, Minghui Ge +4
    Clinical and Experimental MedicinePeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  17. NEDD9 confers ferroptosis resistance in liver cancer by inhibiting autophagy via the AKT‑mTOR signaling pathway
    Qisheng He, Yu Bai, Xiaojing Xu +5
    Biology DirectPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  18. T cell exhaustion in cancer: from functional decline to adaptive immune regulation
    Yanyang Wang, Yang Yu, Jing Zhuang +2
    Molecular CancerPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  19. Fuzheng Yiai Formula and its Key Components Inhibited PCa by TP53/SLC7A11/GPX4-Induced Ferroptosis
    Wen Sheng, Yingqiu Li, Xiaopeng Yu +6
    Biological Procedures OnlinePeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  20. Perioperative Risks of Concurrent Pancreatic and Hepatic Resections for Neuroendocrine Tumors
    Amir Ebadinejad, Ashrita Raghuram, Sophia Xiao +2
    Journal of Surgical OncologyPeer-reviewedCC BY 4.0Full textOncologyPMC
  21. Squeezing Treatment-Induced Metabolic Alterations in Melanoma Cells Are Accompanied by Impaired Cluster of Differentiation 8-Positive T Cell and Natural Killer Cell Antitumor Effector Functions
    Yu Jing, Yunlong Bi
    Cancer Immunology, Immunotherapy : CIIPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  22. Spatially fractionated radiotherapy with PD-L1 blockade achieves superior antitumor efficacy and safety in a preclinical model of peritoneal metastasis
    Sung Eun Lee, Changhoon Choi, Yeeun Kim +4
    Cancer Immunology, Immunotherapy : CIIPeer-reviewedCC BY 4.0Full textOncologyPMC
  23. Repurposing thioridazine as a novel treatment for melanoma brain metastasis
    Tobias Wikerholmen, Erlend Moen Taule, Katharina Sarnow +5
    Cancer Cell InternationalPeer-reviewedCC BY 4.0Full textOncologyPMC
  24. Association between glucose-to-lymphocyte ratio and risk of in-hospital mortality in patients with acute ischemic stroke: a retrospective cohort study based on the MIMIC-IV database.
    Zhilong Xiao, Huangyan Zhou, Min Yuan
    BMC neurologyPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  25. Oncogenic transformation proceeds through a transient state of cellular plasticity constrained by lineage-specific barriers
    Costakis Frangou, Alfiya Safina, Mairead Commane +9
    bioRxivPreprintCC BY-NC-NDFull textOncologyEurope PMCPMC